Brief: Cansino Biologics' 2023 Net Loss At 1.5 Bln Yuan
March 27 (Reuters) - Cansino Biologics Inc
688185.SS 6185.HK :
* SAYS 2023 NET LOSS AT 1.5 BILLION YUAN ($207.57 million)
Source text
Further company coverage: 688185.SS
($1 = 7.2265 Chinese yuan renminbi)
(Reporting by Beijing Newsroom)
((Ethan.Wang@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025